Sulfatrim and Sinus polyp - a phase IV clinical study of FDA data

Summary:

Sinus polyp is reported as a side effect among people who take Sulfatrim (sulfamethoxazole; trimethoprim), especially for people who are female, 60+ old, also take Calcium,.

The phase IV clinical study analyzes which people have Sinus polyp when taking Sulfatrim. It is created by eHealthMe based on reports of 4,093 people who have side effects when taking Sulfatrim from the FDA, and is updated regularly.

What is Sulfatrim?

Sulfatrim has active ingredients of sulfamethoxazole; trimethoprim. eHealthMe is studying from 4,140 Sulfatrim users. Check the latest studies of Sulfatrim.

What is Sinus polyp?

Sinus polyp (abnormal tissue growths that grow inside the nasal passages and sinuses) is found to be associated with 206 drugs and 213 conditions by eHealthMe. Check the latest studies of Sinus polyp.

On Jul, 15, 2026

4,093 people reported to have side effects when taking Sulfatrim.
Among them, 12 people (0.29%) have Sinus polyp.

Among these 12 people:

What is the gender of people who have Sinus polyp when taking Sulfatrim? *

female: 100 %
male: 0.0 %

What is the age of people who have Sinus polyp when taking Sulfatrim? *

What are other drugs people take besides Sulfatrim? *

What are other side effects people have besides Sinus polyp? *

Weakness: 12 people, 100.00%
Pain In Extremity: 12 people, 100.00%
Pulmonary Haemorrhage (acute bleeding from the lung): 11 people, 91.67%
Deafness Unilateral: 11 people, 91.67%
Hypoacusis (loss of hearing): 11 people, 91.67%
Disease Recurrence: 11 people, 91.67%
Nasal Polyps (masses that develop in the lining of the nose): 11 people, 91.67%
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect): 11 people, 91.67%
Skin Blushing/flushing (a sudden reddening of the face, neck): 7 people, 58.33%
Chills (felling of cold): 7 people, 58.33%

* Approximation only. Some reports may have incomplete information.

Do you take Sulfatrim and have Sinus polyp?

- Check whether Sinus polyp is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Sulfatrim:

Sulfatrim (4,140 reports)

Sinus polyp treatments and more:

Sinus polyp (1,381 reports)

How severe was Sinus polyp and when was it recovered:

Sinus polyp in Sulfatrim

Expand to all the drugs that have ingredients of sulfamethoxazole; trimethoprim:

Sinus polyp and drugs with ingredients of sulfamethoxazole; trimethoprim

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Sulfatrim:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Sinus polyp:

Sinus polyp (206 drugs)

Browse all the conditions that are associated with Sinus polyp:

Sinus polyp (213 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on sulfamethoxazole; trimethoprim (the active ingredients of Sulfatrim) and Sulfatrim (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.